IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: Two key steps in specific immunotherapy

FASEB Journal

Volumn 13, Issue 6, 1999, Pages 603-609

  Akdis, Cezmi A ^a   Blaser, Kurt ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

Bee venom; Interleukin 10; Microenvironments; T cell epitopes

Indexed keywords

ALLERGEN; BEE VENOM; CYTOKINE; EPITOPE; GAMMA INTERFERON; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5;

ALLERGY; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGENICITY; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOTHERAPY; PRIORITY JOURNAL; T LYMPHOCYTE;

APOIDEA;

EID: 0032921181     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.6.603     Document Type: Article

References (74)

1. Müller, U. R., Helbling, A., and Berchtold, E. (1992) Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J. Allergy Clin. Immunol 89, 529-535
2. Walker, S. M., Varney, V. A., Gaga, M., Jacobson, M. R., and Durham, S. R. (1995) Grass pollen immunotherapy: efficacy and safety during a 4 year follow-up study. Allergy 50, 405-413
3. Varney, V. A., Gaga, M., Frew, A. J., Aber, V. R., Kay, A. B., and Durham, S. R. (1991) Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by anti-allergic drugs. Br. Med. J. 302, 489-500
4. Hussain, R., Poindexter, R. W., and Ottesen, E. A (1992) Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J. Immunol. 148, 2731-2739
5. Reid, M. J., Moss, R. B., Hsu, Y. P., Kwasnicki, J. M., Commerford, T. M., and Nelson, B. L. (1986) Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy. J. Allergy Clin. Immunol. 78, 590-600
6. 2 antibodies. Arch. Allergy Appl. Immunol 77, 195-197
7. Rocklin, R. E., Sheffer, A., Greineder, D. K., and Melmon, K. L. (1980) Generation of antigen-specific suppressor cells during allergy desensitization. N. Engl. J. Med. 302, 1213-1219
8. Creticos, P. S., Adkinson, N. F., Jr., Kagey-Sabotka, A., Proud, D., Meier, H. L., Naclerio, R. M., Lichtenstein, L. M., and Norman, P. S. (1983) Nasal challenge with ragweed in hay fever patients: effect of immunotherapy. J. Clin. Invest. 76, 2247-2253
9. Rak, S., Rowhagen, O., and Venge, P. (1988) The effect of immunotherapy on bronchial hyper-responsiveness and eosinophil cationic protein in pollen allergic patients. J. Allergy Clin. Immunol. 82, 470-480
10. Otsuka, H., Mezawa, A., Ohnishi, M., Okubo, K., Seki, H., and Okuda, M. (1991) Changes in nasal metachromatic cells during allergen immunotherapy. Clin. Exp. Allergy 21, 115-120
11. Jutel, M., Pichler, W. J., Skrbic, D., Urwyler, A., Dahinden, C., and Müller, U. R. (1995) Bee venom immunotherapy results in decrease of IL4 and IL-5 and increase of IFN-γ secretion in specific allergen stimulated T cell cultures. J. Immunol. 154, 4178-4194
12. Secrist, H., Chelen, C. J., Wen, Y., Marshall, J. D., and Umetsu, D. T. (1993) Allergen immunotherapy decreases interleukin 4 production in CD4T cells from allergic individuals. J. Exp. Med. 178, 2123-2130
13. Bellinghousen, I., Metz, G., Enk, A. H., Christmann, S., Knop, J., and Saloga, J. (1997) Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur. J. Immunol. 27, 1131-1139
14. 2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J. Clin. Invest. 98, 1676-1683
15. Akdis, C. A., Blesken, T., Akdis, M., Wüthrich, B., and Blaser, K. (1998) The role of IL-10 in specific immunotherapy. J. Clin. Invest. 102, 98-106
16. 2 induces specific T cell anergy in bee sting allergic patients. J. Allergy Clin. Immunol. 101, 747-754
17. Marcotte, G. V., Braun, C. M., Norman, P. S., Nicodemus, C. F., Kagey-Sabotka, A., Lichtenstein, L. M., and Essayan, D. M. (1998) Effects of peptide therapy on ex vivo T cell responses. J. Allergy Clin. Immunol. 101, 506-513
18. Parijs, L. V., and Abbas, A. K. (1998) Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280, 243-248
19. Essery, G., Feldmann, M., and Lamb, J. (1988) Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes. Immunol. 64, 413-417
20. Kagey-Sabotka, A., Franklin, R. M., Adkinson, N. F., Jr., Valentine, M., Bauer, H., and Lichtenstein, L. M. (1976) Allergy to insect sting II. Phospholipase A: the major allergen in honey bee venom. J. Allergy Clin. Immunol. 57, 29-40
21. Müller, U. R., Dudler, T., Schneider, T., Crameri, R., Fischer, H., Skrbic, D., Maibach, R., Blaser, K., and Suter, M. (1995) Type 1 skin reactivity to native and recombinant phospholipase A2 from honey bee venom is similar. J. Allergy Clin. Immunol. 96, 395-402
22. Akdis, C. A., Blesken, T., Akdis, M., Alkan, S. S., Wüthrich, B., Heusser, C. H., and Blaser, K. (1997) Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and non-specific activation of T and B cells. J. Allergy Clin. Immunol. 99, 345-352
23. Akdis, C. A., Blesken, T., Akdis, M., Alkan, S. S., Heusser, C. H., and Blaser, K. (1997) Glucocorticoids inhibit human antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro. Eur. J. Immunol. 27, 2351-2357
24. 2. J. Immunol. 150, 3582-3591
25. Creticos, P. S. (1992) Immunological changes associated with immunotherapy. In Immunotherapy of IgE Mediated Disorders (Greenberger, P. A., ed) pp. 13-37, W. B. Saunders, Philadelphia
26. Greenstein, J. L., Morgenstern, J. P., LaRaia, J., Counsell, C. M., Goodwin, W. H., Lussier, A., Creticos, P. S., Norman, P. S., and Garman, R. D. (1992) Ragweed immunotherapy decreases T cell reactivity to recombinant Amb a I.1. J Allergy Clin. Immunol. 89, 322
27. Hoyne, G. F., O'Hehir, R., Wraith, D. C., Thomas, W. R., and Lamb, J. R. (1993) Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J. Exp. Med. 178, 1783-1788
28. Briner, T., Kou, M., Keating, K., Rogers, B., and Greenstein, J. (1993) Peripheral T cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I. Proc. Natl. Acad. Sci. U. S. A. 90, 7608-7612
29. Norman, P., Ohmann Jr, J. L., Long, A. A., Creticos, P. S., Gefter, M. A., Shaked, Z., Wood, R., Eggleston, P., Lichtenstein, L. M., and Jones, N. (1996) Treatment of cat allergy with T cell reactive peptides. Am. J. Resp. Crit. Care Med. 154, 1623-1628
30. lck and ZAP-70 tyrosine kinase activities. J. Immunol. 159, 53-60
31. Florentino, D. F., Bond, M. W., and Mosmann, T. R. (1989) Two types of mouse T helper cell IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170, 2081-2095
32. Florentine, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., and O'Garra, A. (1991) IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815-3822
33. De Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., and De Vries, J. E. (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220
34. Hsu, D. H., Moore, K. W., and Spits, H. (1992) Differential effects of interleukin-4 and -10 on interleukin-2 induced interferon-γ synthesis and lymphokine activated killer activity. Int. Immunol. 4, 563-569
35. Del Prete, G., De Carli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R., and Romagnani, S. (1993) Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150, 353-356
36. Zuany-Amorim, C., Haile, S., Leduc, D., Dumarey, C., Huerre, M., Vergaftig, B. B., and Pretolani, M. (1995) Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J. Clin. Invest. 95, 2644-2651
37. Zuany-Amorim, C., Creminon, C., Nevers, M. C., Nahori, M. -A., Vergaftig, B. B., and Pretolani, M. (1996) Modulation by IL-10 of antigen-induced IL-5 generation, and CD4+ T lymphocyte and eosinophil infiltration into the mouse peritoneal cavity. J. Immunol. 157, 377-384
38. Schandane, L., Alonso-Vega, C., Willems, F., Gerard, C., Delvaux, A., Velu, T., Devos, R., de Boer, M., and Goldman, M. (1994) B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol. 152, 4368-4374
39. Ding, L., and Shevach, E. M. (1992) IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage co-stimulatory function. J. Immunol. 148, 3133-3139
40. Lamb, J. R., Skidmore, B. J., Green, N., Chiller, J. M., and Feldman, M. (1983) Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J. Exp. Med. 157, 1434-1447
41. Wang, P., Wu, P., Siegel, M. I., Egan, R. W., and Billah, M. M. (1994) IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 153, 811-816
42. Bogdan, C., Paik, J., Vodovotz, Y., and Nathan, C. (1992) Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J. Biol. Chem. 267, 23301-23310
43. Enk, A. H., Saloga, J., Becker, D., Mohamadzadeh, M., and Knop, J. (1994) Induction of hapten-specific tolerance by interleukin 10 in vivo. J. Exp. Med. 179, 1397-1402
44. Bacetta, R., Bigler, M., Touraine, J. -T., Parkman, R., Tovo, P. -A., Abrams, J., and De Waal Malefyt, R. (1994) High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 179, 493-502
45. Becker, J., Czerny, C. C., and Bröcker, E. -B. (1994) Maintenance of clonal anergy by endogenously produced IL-10. Int. Immunol. 6, 1605-1612
46. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (London) 389, 737-742
47. Gaglani, B., Borish, L., Bartelson, B. L., Bucheimer, A., Keller, L., Nelson, H. S. (1997) Nasal immunotherapy in weed-induced allergic rhinitis. Annals of Allergy, Asthma, and Immunology 79, 259-265
48. Ippoliti, F., Ragno, V., Del Nero, A., McEwen, N. M., McEwen, H., and Businco, L. (1997) Effect of preseasonal enzyme potentiated desensitization (EPD) on plasma IL-6 and IL-10 of grass pollen-sensitive asthmatic children. Allerg. Immunol. (Paris) 29, 123-125
49. Grabstein, K. H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C., Richardson, J., Schoenborn, M. A., Ahdieh, M., Johnson, L., Anderson, M. R., Watson, J. D., Anderson, D. M., and Giri, J. G. (1994) Cloning of a T cell growth factor which interacts with the γ chain of the interleukin-2 receptor. Science 264, 965-968
50. Aalberse, R. C., Van der Gaag, R., and van Leuwen, J. (1983) Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J. Immunol. 130, 722-726
51. Lucas, A. H. (1990) IgG subclass restricted immune responses to allergens. Springer Semin. Immunopathol. 12, 385-420
52. Wyss, M., Scheitlin, T., Stadler, B. M., and Wüthrich, B. (1993) Immunotherapy with aluminium hydroxide adsorbed insect venom extracts (Alutard SQ): immunologic and clinical results of a prospective study over 3 years. Allergy 48, 81-86
53. Ortolani, C., Pastorello, E. A., Incorvaia, C., Ispano, M., Farioli, L., Zara, C., Pravettoni, V., and Zanussi, C. (1994) A double-blind, placebo-controlled study of immunotherapy with an alginate-conjugated extract of Parietaria judaica in patients with Parietaria hay fever. Allergy 49, 13-21
54. Tsai, L. C., Tang, R. B., Hung, M. W., and Chang, Z. N. (1991) Changes in levels of house dust mite specific IgG4 during immunotherapy in asthmatic children. Clin. Exp. Allergy 21, 367-372
55. Bertelsen, A., Andersen, J. B., Christensen, J., Ingemann, L., Kristensen, T., and Ostergaard, P. A. (1989) Immunotherapy with dog and cat extracts in children. Allergy 44, 330-335
56. Punnonen, J., De Waal Malefyt, R., Van Vlasselaer, P., Gauchat, J.-F., and De Vries, J. E. (1993) IL-10 and viral IL-10 prevent IL-4-indiced IgE synthesis by inhibiting the accessory cell function of monocytes. J. Immunol. 151, 1280-1289
57. Müller, U. R., and Mosbech, H. (1993) Position paper: Immunotherapy with hymenptera venoms. Allergy 48, 36-46
58. Jutel, M., Müller, U. M., Fricker, M., Rihs, S., Pichler, W., and Dahinden, C. (1996) Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils. Clin. Exp. Allergy 26, 112-1118
59. Akdis, C. A. (1997) Glucocorticoids. In Strategies for Immunointervention in Dermatology (Burg, G., and Dummer, R., eds) pp. 131-146, Springer-Verlag, Heidelberg
60. Hamaguchi, Y., Kanakura, Y., Fujita, T., Takeda, S., Nakano, T., Tauri, S., Honjo, T., and Kitamura, Y. (1987) Interleukin 4 is an essential factor for in vitro clonal growth of murine connective tissue-type mast cells. J. Exp. Med. 165, 268-273
61. Kuna, P., Reddigari, S. R., Schall, T. J., Rucinski, D., Sadick, M., and Kaplan, A. P. (1993) Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J. Immunol. 150, 1932-1943
62. Schleimer, R. P., Derse, C. P., Friedman, B., Gillis, S., Plaut, M., Lichtenstein, L. M., and MacGlashan, D. W., Jr. (1989) Regulation of human basophil mediator release by cytokines. I. Interaction with anti-inflammatory steroids. J. Immunol. 143, 1310-1327
63. Walker, C., Virchow, J-C., Bruijnzeel, P. L. B., and Blaser, K. (1991) T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J. Immunol. 146, 1829-1835
64. Arock, M., Zuany-Amorim, C., Singer, M., Benhamou, M., and Pretolani, M. (1996) Interleukin-10 inhibits cytokine generation from mast cells. Eur. J. Immunol. 26, 166-170
65. Marshall, J. S., Leal-Berumen, I., Nielsen, L., Glibetic, M., and Jordana, M. (1996) Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J. Clin. Invest. 97, 1122-1128
66. Pretolani, M., and Goldman, M. (1997) IL-10: a potential therapy for allergic inflammation? Immunol. Today 18, 277-280
67. Takanaski, S., Nonaka, R., Xing, Z., O'Byrne, P., Dolovich, J., and Jordana, M. (1994) Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J. Exp. Med. 180, 711-715
68. Ohkawara, Y., Lim, K. G., Glibetic, M., Nakano, K., Dolovich, J., Croitoru, K., Weller, P. F., and Jordana, M. (1996) CD40 expression by human peripheral blood eosinophils. J. Clin. Invest. 97, 1761-1766
69. + T cells in human immunodeficiency virus-infected individuals. J. Exp. Med. 179, 413-424
70. Mahanty, S., Mollis, S. N., Ravichandran, M., Abrams, J. S., Kumaraswami, V., Jayaraman, K., Ottesen, E. A., and Nutman, T. B. (1996) High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J. Infect. Dis. 173, 769-773
71. Müller, U., Helbling, A., and Berchtold, E. (1992) Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safery. J. Allergy Clin. Immunol. 89, 529-535
72. Schandene, L., Alonso-Vega, C.,. Willems, F., Gerard, C., Delvaux, A., Velu, T., Devos, R., de Boer, M., and Goldman, M. (1994) B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol 152, 4368-4374.
73. Rudd, C. E. (1996) Upstream-Downstream CD28 cosignaling pathways and T cell function. Immunity 4, 527-534.
74. Ward, S. G., Westwick, J., Hall, N. D., Sansom, D. M. (1993) Ligation of CD28 by B7 induces formation of D-3 phosphoinositides in T lymphocytes independently of T cell receptor/ CD3 activation. Eur. J. Immunol. 23, 2572-2577